Key Insights

Highlights

Success Rate

100% trial completion (above average)

Treatment Research

2 treatments under study, led by Duraprep

Related Conditions

Often studied with 4 related conditions

Clinical Risk Assessment

Based on trial outcomes

Low Risk

Score: 5/100

Termination Rate

0.0%

0 terminated out of 1 trials

Success Rate

100.0%

+13.4% vs benchmark

Late-Stage Pipeline

100%

1 trials in Phase 3/4

Results Transparency

100%

1 of 1 completed with results

Key Signals

1 with results100% success

Data Visualizations

Phase Distribution

1Total
Phase 4 (1)

Trial Status

Completed1

Trial Success Rate

100.0%

Benchmark: 86.6%

Based on 1 completed trials

Clinical Trials (1)

Research Network

Common Treatments

  • Duraprep1
  • Chloraprep1

Active Sponsors

  • McMaster University1
  • Patient-Centered Outcomes Research Institute1
  • University of Maryland, Baltimore1

Top Investigators

Related Conditions

  • Surgical Site Infection1
  • Open Appendicular Fracture1
  • Pelvic Fracture1
  • Unplanned Fracturerelated Reoperation1

Activity Timeline